Abstract
BACKGROUND AND AIMS: Administration of omeprazole to healthy volunteers was recently reported to increase proximal duodenal mucosal bicarbonate secretion. As human oesophagus also secretes bicarbonate, the hypothesis was tested that omeprazole may stimulate oesophageal bicarbonate secretion and thus contribute to the therapeutic efficacy of the drug in gastro-oesophageal reflux disease. SUBJECTS AND METHODS: In nine healthy volunteers, oesophageal "steady state" perfusion of a 10 cm open segment of distal oesophagus was performed twice in random order. The volunteers were pretreated with either 60 mg/day omeprazole for three days and 80 mg intravenous omeprazole before perfusion or 600 mg/day ranitidine for three days and 50 mg/h intravenously during the perfusion. Saliva and samples of aspirate from the perfused oesophagus and stomach were collected and bicarbonate concentrations were measured. RESULTS: The median rates (95% confidence intervals) of intrinsic oesophageal bicarbonate secretion, corrected for contaminating salivary and gastric bicarbonate, were 89 (33-150) and 121 (63-203) mumol/h/10 cm (p > 0.5) in omeprazole and ranitidine treated subjects respectively. Salivary and gastric bicarbonate contaminating the oesophagus accounted for 14% and 3%, respectively, of total oesophageal bicarbonate output. CONCLUSIONS: Bicarbonate secretory capacity of the human oesophagus is less than previously assumed, and the clinical relevance of intrinsic oesophageal bicarbonate for mucosal defence may be overestimated. As omeprazole and ranitidine did not affect bicarbonate secretion differently there was no evidence that omeprazole acts on bicarbonate secretory cells in the oesophageal mucosa.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bate C. M., Booth S. N., Crowe J. P., Mountford R. A., Keeling P. W., Hepworth-Jones B., Taylor M. D., Richardson P. D. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group. Gut. 1995 Apr;36(4):492–498. doi: 10.1136/gut.36.4.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown C. M., Snowdon C. F., Slee B., Sandle L. N., Rees W. D. Effect of topical oesophageal acidification on human salivary and oesophageal alkali secretion. Gut. 1995 May;36(5):649–653. doi: 10.1136/gut.36.5.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown C. M., Snowdon C. F., Slee B., Sandle L. N., Rees W. D. Measurement of bicarbonate output from the intact human oesophagus. Gut. 1993 Jul;34(7):872–880. doi: 10.1136/gut.34.7.872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collen M. J., Strong R. M. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci. 1992 Jun;37(6):897–903. doi: 10.1007/BF01300388. [DOI] [PubMed] [Google Scholar]
- Dent J., Dodds W. J., Friedman R. H., Sekiguchi T., Hogan W. J., Arndorfer R. C., Petrie D. J. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980 Feb;65(2):256–267. doi: 10.1172/JCI109667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hallerbäck B., Unge P., Carling L., Edwin B., Glise H., Havu N., Lyrenäs E., Lundberg K. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group. Gastroenterology. 1994 Nov;107(5):1305–1311. doi: 10.1016/0016-5085(94)90531-2. [DOI] [PubMed] [Google Scholar]
- Hamilton B. H., Orlando R. C. In vivo alkaline secretion by mammalian esophagus. Gastroenterology. 1989 Sep;97(3):640–648. doi: 10.1016/0016-5085(89)90635-5. [DOI] [PubMed] [Google Scholar]
- Helm J. F., Dodds W. J., Hogan W. J. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology. 1987 Dec;93(6):1393–1397. doi: 10.1016/0016-5085(87)90270-8. [DOI] [PubMed] [Google Scholar]
- Helm J. F., Dodds W. J., Hogan W. J., Soergel K. H., Egide M. S., Wood C. M. Acid neutralizing capacity of human saliva. Gastroenterology. 1982 Jul;83(1 Pt 1):69–74. [PubMed] [Google Scholar]
- Helm J. F., Dodds W. J., Pelc L. R., Palmer D. W., Hogan W. J., Teeter B. C. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med. 1984 Feb 2;310(5):284–288. doi: 10.1056/NEJM198402023100503. [DOI] [PubMed] [Google Scholar]
- Knutson L., Flemström G. Duodenal mucosal bicarbonate secretion in man. Stimulation by acid and inhibition by the alpha 2-adrenoceptor agonist clonidine. Gut. 1989 Dec;30(12):1708–1715. doi: 10.1136/gut.30.12.1708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mertz-Nielsen A., Hillingsø J., Bukhave K., Rask-Madsen J. Indomethacin decreases gastroduodenal mucosal bicarbonate secretion in humans. Scand J Gastroenterol. 1995 Dec;30(12):1160–1165. doi: 10.3109/00365529509101625. [DOI] [PubMed] [Google Scholar]
- Mertz-Nielsen A., Hillingsø J., Bukhave K., Rask-Madsen J. Omeprazole promotes proximal duodenal mucosal bicarbonate secretion in humans. Gut. 1996 Jan;38(1):6–10. doi: 10.1136/gut.38.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers R. L., Orlando R. C. In vivo bicarbonate secretion by human esophagus. Gastroenterology. 1992 Oct;103(4):1174–1178. doi: 10.1016/0016-5085(92)91501-t. [DOI] [PubMed] [Google Scholar]
- Van Dis M. L., Vincent S. D. Diagnosis and management of autoimmune and idiopathic mucosal diseases. Dent Clin North Am. 1992 Oct;36(4):897–917. [PubMed] [Google Scholar]
- Wilde M. I., McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs. 1994 Jul;48(1):91–132. doi: 10.2165/00003495-199448010-00008. [DOI] [PubMed] [Google Scholar]
